IGF-I affects glycosaminoglycan/proteoglycan synthesis in breast cancer cells through tyrosine kinase-dependent and -independent pathways

Biochimie

Volumn 86, Issue 4-5, 2004, Pages 251-259

  Mitropoulou, Theoni N ^a   Theocharis, Achilleas D ^a   Nikitovic, Dragana ^b   Karamanos, Nikos K ^a   Tzanakakis, George N ^b  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

Breast cancer; chondroitin sulphate; CS; dermatan sulphate; DS; ER; estrogen receptor; GAG; galactosaminoglycan containing proteoglycans; galactosaminoglycans; GalAGPGs; GalAGs; Genistein; glycosaminoglycan; Glycosaminoglycans; HA; HS; hyaluronan; IGF I; Proteoglycans

Indexed keywords

ESTROGEN RECEPTOR; GALACTOSAMINOGLYCAN; GENISTEIN; HYALURONIC ACID; PROTEIN TYROSINE KINASE; PROTEOGLYCAN; PROTEOHEPARAN SULFATE; SOMATOMEDIN C; SOMATOMEDIN RECEPTOR;

ARTICLE; BIOSYNTHESIS; BREAST CANCER; CANCER CELL; CELL CULTURE; CELL LINE; CELL MEMBRANE; CELL STRAIN MCF 7; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIUM CELL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; PROTEOGLYCAN SYNTHESIS; SIGNAL TRANSDUCTION; UPREGULATION;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL MEMBRANE; DRUG COMBINATIONS; EPITHELIAL CELLS; GENISTEIN; GLYCOSAMINOGLYCANS; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; HYALURONIC ACID; INSULIN-LIKE GROWTH FACTOR I; PROTEIN-TYROSINE KINASES; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 2942640103     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biochi.2004.04.008     Document Type: Article

References (45)

1. Conrad H.E. Heparin-binding Proteins. 1997;Academic Press, Inc. San Diego
2. Bernfield M., Götte M., Park P.W., Reizes O., Fitzgerald M.L., Lincecum J., Zako M. Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 68:1999;729-777
3. Karamanos N.K. Proteoglycans: biological roles and strategies for isolation and determination of their glycan constituents. Kamp M., Kyriakides D., Choli-Papadopoulou D. Proteome and Protein Analysis. 1999;341-363 Verlag, Heidelberg
4. Khellen L., Lindahl U. Proteoglycans: structures and interactions. Ann. Rev. Biochem. 60:1991;443-475
5. Iozzo R.V. The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. Crit. Rev. Biochem. Mol. Biol. 32:1998;141-174
6. Delehedde M., Deudon E., Boilly B., Hondermarck H. Production of sulfated proteoglycans by human breast cancer cell lines. Binding to fibroblast growth factor-2. J. Cell. Biochem. 64:1997;605-617
7. Mitropoulou T.N., Tzanakakis G.N., Nikitovic D., Tsatsakis A., Karamanos N.K. In vitro effects of genistein on the synthesis and distribution of glycosaminoglycans/proteoglycans by estrogen receptor-positive and -negative human breast cancer epithelial cells. Anticancer Res. 22:2002;2841-2846
8. Aaronson S.A. Growth factors and cancer. Science. 254:1991;1146-1153
9. Cross M., Dexter T.M. Growth factors in development, transformation and tumorigenesis. Cell. 64:1991;271-280
10. Bishop J.M. Cellular oncogenes and retroviruses. Annu. Rev. Biochem. 52:1983;301-354
11. Peterson G. Evaluation of the biochemical targets of genistein in tumor cells. J. Nutr. 125:(Suppl. 3):1995;698S-708S
12. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M., Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262:1987;5592-5595
13. Macaulay V.M. Insulin-like growth factors and cancer. Br. J. Cancer. 65:1992;311-320
14. LeRoith D., Baserga R., Helman L., Roberts C.T. Jr. Insulin-like growth factors and cancer. Ann. Intern. Med. 122:1995;54-59
15. Pollak M.N. Endocrine effects of IGF-I on normal and transformed breast epithelial cells: potential relevance to strategies for breast cancer treatment and prevention. Breast Cancer Res. Treat. 47:1998;209-217
16. Dunn S.E., Hardman R.A., Kari F.W., Barrett J.C. Insulin-like growth factor 1 (IGF-1) alters drug sensitivity of HBL-100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs. Cancer Res. 57:1997;2687-2693
17. Nickerson T., Huynh H., Pollak M. Insulin-like growth factor binding protein-3 induces apoptosis in MCF-7 breast cancer cells. Biochem. Biophys. Res. Commun. 237:1997;690-693
18. Liu Y., Lehar S., Corvi C., Payne G., O'Connor R. Expression of the insulin-like growth factor I receptor C terminus as a myristylated protein leads to induction of apoptosis in tumor cells. Cancer Res. 58:1998;570-576
19. LeRoith D., Werner H., Beitner-Johnson D., Roberts C.T. Jr. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr. Rev. 16:1995;143-162
20. Sepp-Lorenzino L. Structure and function of the insulin-like growth factor I receptor. Breast Cancer Res. Treat. 47:1998;235-253
21. Kelley K.M., Oh Y., Gargosky S.E., Gucev Z., Matsumoto T., Hwa V., Ng L., Simpson D.M., Rosenfeld R.G. Insulin-like growth factor-binding protein (IGFBPs) and their regulatory dynamics. Int. J. Biochem. Cell. Biol. 28:1996;619-637
22. Clemmons D.R. Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factors Rev. 8:1997;45-62
23. Jones J.I., Clemmons D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16:1995;3-34
24. Roussids A.E., Karamanos N.K. Inhibition of receptor tyrosine kinase-based signal transduction as specific target for cancer treatment. In vivo. 16:2002;459-470
25. Xie Y., Skytting B., Nilsson G., Brodin B., Larsson O. Expression of insulin-like growth factor-1 receptor in synovial sarcoma: association with an aggressive phenotype. Cancer Res. 59:1999;3588-3591
26. Hakam A., Yeatman T.J., Lu L., Mora L., Marcet G., Nicosia S.V., Karl R.C., Coppola D. Expression of insulin-like growth factor-1 receptor in human colorectal cancer. Hum. Pathol. 30:1999;1128-1133
27. Lee A.V., Jackson J.G., Gooch J.L., Hilsenbeck S.G., Coronado-Heinsohn E., Kent Osborne C., Yee D. Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo. Mol. Endocrinol. 13:1999;787-796
28. Yee D., Lee A.V. Crosstalk between the insulin-like growth factor and estrogens in breast cancer. J. Mammary Gland Biol. Neoplasia. 5:2000;107-115
29. Corbin C., Graham-Lorence S., McPhaul M., Mason J., Mendelson C., Simpson E. Isolation of a full-length cDNA insert encoding human aromatase system cytochrome P-450 and its expression in nonsteroidogenic cells. Proc. Natl. Acad. Sci. USA. 85:1988;8948-8952
30. Scott J.E. Click D. Methods Biochemical Analysis. 1960;145-197 Interscience, New York
31. Antonopoulos C.A., Borelious E., Hamnström B., Scott J.E. The precipitation of polyanions by long-chain aliphatic ammonium compounds. Elution in salt solutions of mucopolysaccharide-quaternary ammonium complexes absorbed on a support. Biochim. Biophys. Acta. 54:1961;213-226
32. Yamagata T., Saito H., Habuchi O., Suzuki S. Purification and properties of bacterial chondroitinases and chondrosulfatases. J. Biol. Chem. 243:1968;1523-1535
33. Karamanos N.K., Syrokou A., Vanky P., Nurminen M., Hjerpe A. Determination of twenty-four variously sulfated galactosaminoglycan and hyaluronan-derived disaccharides by high performance liquid chromatography. Anal. Biochem. 221:1994;189-199
34. Karamanos N.K., Axelsson S., Vanky P., Tzanakakis G.N., Hjerpe A. Determination of hyaluronan and galactosaminoglycan disaccharides by high performance capillary electrophoresis at the attomole level. Applications to analyses of tissue and cell culture proteoglycans. J. Chromatogr. A. 696:1995;295-305
35. Mitropoulou T.N., Lamari F., Syrokou A., Hjerpe A., Karamanos N.K. Identification of oligomeric domains within dermatan sulfate chains using differential enzymic treatments, derivatization with 2-aminoacridone and capillary electrophoresis. Electrophoresis. 22:2001;2458-2463
36. Hashimoto N., Morikava K., Kikuchi M., Yoshida K., Tokuyasu K. Purification and properties of a new keratan sulfate degrading enzyme. Seikagaku. 60:1988;935-938
37. Linker A., Conrad H.E. Heparinase and heparitinase from Flavobacteria. Methods Enzymol. 28:1972;902-911
38. Karamanos N.K., Vanky P., Tzanakakis G.N., Tsegenidis T., Hjerpe A. Ion-pair high-performance liquid chromatography for detecting disaccharide composition in heparin and heparan sulphate. J. Chromatogr. A. 765:1997;169-179
39. Karamanos N.K., Vanky P., Tzanakakis G.N., Hjerpe A. High performance capillary electrophoresis method to characterize heparin and heparan sulfate disaccharides. Electrophoresis. 17:1996;391-395
40. Timar J., Lapis K., Dudas J., Sebestyen A., Kopper L., Kovalszky I. Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer. Cancer Biol. 12:2002;173-186
41. Bartucci M., Morelli C., Mauro L., Ando S., Surmacz E. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells. Cancer Res. 61:2001;6747-6754
42. Baciu P., Goetnick P.F. Protein kinase C regulates the recruitment of syndecan-4 into focal contacts. Mol. Biol. Cell. 6:1995;1503-1513
43. Iozzo R.V. Matrix proteoglycans: from molecular design to cellular function. Ann. Rev. Biochem. 67:1998;609-652
44. Tsara M.E., Theocharis A.D., Theocharis D.A. Compositional and structural alterations of proteoglycans in human rectum carcinoma with special reference to versican and decorin. Anticancer Res. 22:2002;2893-2898
45. Gulyas M., Hjerpe A. Proteoglycans and WT1 as markers for distinguishing adenocarcinoma, epithelioid mesothelioma, and benign mesothelium. J. Pathol. 199:2003;479-487